Skip to content
Twitter page opens in new windowLinkedin page opens in new windowInstagram page opens in new windowYouTube page opens in new window
[email protected]+61 3 9692 7222
PharmAust (PAA)
Cancer Therapeutics Research
PharmAust (PAA)
  • HOME
  • ABOUT
    • Board
    • Management
    • Corporate Directory
  • PIPELINES & TRIALS
    • Monepantel for Motor Neurone Disease
    • Publications
  • INVESTOR HUB
    • ASX Announcements
    • Annual Reports
    • Investor Presentations
    • Analyst Reports
    • Financial Reports
    • Corporate Governance
    • Top 20 Shareholders
  • MEDIA
    • Videos
    • Media
  • CONTACT
  • HOME
  • ABOUT
    • Board
    • Management
    • Corporate Directory
  • PIPELINES & TRIALS
    • Monepantel for Motor Neurone Disease
    • Publications
  • INVESTOR HUB
    • ASX Announcements
    • Annual Reports
    • Investor Presentations
    • Analyst Reports
    • Financial Reports
    • Corporate Governance
    • Top 20 Shareholders
  • MEDIA
    • Videos
    • Media
  • CONTACT

Author Archives: PharmAust

Appendix 4G & Corporate Governance Statement

Financial Reports 2016, News & Announcements 2016By PharmAust30/06/2016

160831_Appendix 4G & Corporate Governance Statement

University of Cambridge to begin Phase II Trial

News & Announcements 2016By PharmAust27/06/2016

160627_University of Cambridge to begin Phase II Trial

Epichem Successful in AusTrade Grant

News & Announcements 2016By PharmAust16/06/2016

160616_ Epichem Successful in AusTrade Grant

Epichem Successful in AusTrade Grant

News & Announcements 2016By PharmAust16/06/2016

160616_ Epichem Successful in AusTrade Grant

Hospital

By PharmAust11/05/2016

Mandate signed to raise capital in USA & list on NASDAQ

News & Announcements 2016By PharmAust03/05/2016

160602_Mandate signed to raise capital in USA & list on NASDAQ

Appendix 4C Quarterly Report & Brief Company Update

Financial Reports 2016, News & Announcements 2016By PharmAust29/04/2016

160429_Appendix 4C Quarterly Report & Brief Company Update

RedChip issues research on PharmAust

News & Announcements 2016By PharmAust11/03/2016

160311_RedChip issues research on PharmAust

Strategy for Phase II Clinical Trial of Monepantel

News & Announcements 2016By PharmAust08/03/2016

160308_Strategy for Phase II Clinical Trial of Monepantel

Redchip

Research Notes 2016By PharmAust08/03/2016

160308_Redchip Research Note

←1
234567891011121314151617181920212223242526272829303132333435363738394041
…4243444546…
4748495051
52→
MENU
  • Home
  • About Us
  • Pipeline & Trials
  • Investor Centre
  • Media
  • Contact Us
SUBSCRIBE TO OUR NEWSLETTER

PharmAust Follow

PharmAust is a clinical-stage biotech company focused on repurposing monepantel (MPL) for human neurodegenerative diseases ASX: $PAA FSE: $ECQ

PharmAust
pharmaust PharmAust @pharmaust ·
24 Jun

📸 Highlights from the MND Australia Global Day Event at Parliament House!

We teamed up with FightMND to raise awareness and fight for a future free of Motor Neurone Disease. 💙

#MNDAustralia #FightMND #MNDGlobalDay

Reply on Twitter 1805134834358210569 Retweet on Twitter 1805134834358210569 2 Like on Twitter 1805134834358210569 12 Twitter 1805134834358210569
Retweet on Twitter PharmAust Retweeted
stockheadau Stockhead @stockheadau ·
21 Jun

Stockhead’s Break it Down brings you today’s leading market news in under 90 seconds.
#ASX @PharmAust

Reply on Twitter 1803984607676654065 Retweet on Twitter 1803984607676654065 1 Like on Twitter 1803984607676654065 3 Twitter 1803984607676654065
pharmaust PharmAust @pharmaust ·
21 Jun

Exciting news for our investors! 🎉 Check out the details of our latest capital raise here: https://investorhub.pharmaust.com/investment-offer/32. Thank you for your continued support! 🌟 #PharmAust

Reply on Twitter 1804030728956711230 Retweet on Twitter 1804030728956711230 2 Like on Twitter 1804030728956711230 7 Twitter 1804030728956711230
Load More

Copyright © 2024 PharmAust. All rights reserved.
nil

Website Design & Digital Marketing Perth by Total Click Solutions

Go to Top